1-Methylindazole-3-Carboxylic Acidum CAS 50890-83-0 Puritas >99.0% (HPLC) Granisetron Hydrocholride Intermedia Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 1-Methylindazole-3-Carboxylic Acid (CAS: 50890-83-0) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com
Nomen chemicum | 1-Methylindazole-3-Carboxylic acid |
Synonyma | 1-Methyl-1H-Indazole-3-Carboxylic Acidum |
immunditia | Granisetron Related Compound D;Granisetron EP |
CAS Number | 50890-83-0 |
CATTUS Number | RF2673 |
Stock Status | In Stock, Productio Capacitas 25 Tons per Month |
Formulae hypotheticae | C9H8N2O2 |
M. Pondus | 176.18 |
Liquescens punctum | 213.0~ 218.0℃ |
Ferveret | 383.7±15.0℃ |
Density | 1.35±0.1 g/cm |
Solubilitas in aqua | Insolubilis in aqua.Solutum in DMSO et Methanolum |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White Crystalline pulveris |
Puritas / Analysis Methodus | >99.0% (HPLC Area) |
Puritas / Analysis Methodus | 99.0~ 102.5% (Titratio NaOH) |
Liquescens punctum | 213.0~ 218.0℃ |
Damnum in Siccatio | <0.50% |
Cinis sululated | <0.10% |
Substantiae cognatae | |
Indazole Acidum | <0.50% |
2-Methylindazole Acidum | <0.50% |
Alia immunitas | <0.50% |
Totalis Related Impurities | <1.00% |
Infrared Imaginis | Conformat ut Structure |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Granisetron Hydrocholride (CAS: 107007-99-8) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
1-Methylindazole-3-carboxylicum acidum (CAS: 50890-83-0) medium est hydrocholride Granisetron (CAS: 107007-99-8).Granisetron hydrochloridum valde selectivum 5-HT3 receptor antagonista est, quae bona praecaventia et therapeutica in nausea et vomitu effectus radiotherapiae, chemotherapy et chirurgiae causatur.Factores, ut sunt radiotherapiae, chemotherapy et chirurgiae, emissionem 5-HT ab cellulis intestinorum chromaffinorum inducere possunt, et 5-HT receptorem 5-HT3 in nervo centrali vel vagi movere et vomitum reflexum movere.Mechanismus nauseae et vomitus ab hoc facto continentes est inhibitio nauseae et vomitus contra receptores 5-HT3 in area chemoreceptor centralis et terminales peripherici vagales. Granisetron hydrochloridum altam selectionem, nullam reactionem extrapyramidalem, nimiam sedationem et alia parte effectus habet.